nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclophosphamide—CYP2A6—stomach cancer	0.339	1	CbGaD
Cyclophosphamide—ABCB1—Mitomycin—stomach cancer	0.0528	0.138	CbGbCtD
Cyclophosphamide—CYP2A6—Fluorouracil—stomach cancer	0.039	0.102	CbGbCtD
Cyclophosphamide—CYP3A7—Irinotecan—stomach cancer	0.0278	0.0723	CbGbCtD
Cyclophosphamide—CYP3A7-CYP3A51P—Irinotecan—stomach cancer	0.0278	0.0723	CbGbCtD
Cyclophosphamide—CYP2B6—Irinotecan—stomach cancer	0.0264	0.0689	CbGbCtD
Cyclophosphamide—CYP2C9—Capecitabine—stomach cancer	0.0226	0.0589	CbGbCtD
Cyclophosphamide—CYP3A5—Irinotecan—stomach cancer	0.0208	0.0543	CbGbCtD
Cyclophosphamide—CYP3A7—Docetaxel—stomach cancer	0.0203	0.053	CbGbCtD
Cyclophosphamide—CYP3A7-CYP3A51P—Docetaxel—stomach cancer	0.0203	0.053	CbGbCtD
Cyclophosphamide—CYP2C8—Fluorouracil—stomach cancer	0.0192	0.0501	CbGbCtD
Cyclophosphamide—CYP3A5—Docetaxel—stomach cancer	0.0153	0.0398	CbGbCtD
Cyclophosphamide—CYP2B6—Doxorubicin—stomach cancer	0.0144	0.0376	CbGbCtD
Cyclophosphamide—ABCB1—Irinotecan—stomach cancer	0.0136	0.0353	CbGbCtD
Cyclophosphamide—CYP2C9—Fluorouracil—stomach cancer	0.0134	0.0349	CbGbCtD
Cyclophosphamide—ABCB1—Docetaxel—stomach cancer	0.00993	0.0259	CbGbCtD
Cyclophosphamide—CYP3A4—Irinotecan—stomach cancer	0.00812	0.0212	CbGbCtD
Cyclophosphamide—ABCB1—Doxorubicin—stomach cancer	0.0074	0.0193	CbGbCtD
Cyclophosphamide—ABCB1—Methotrexate—stomach cancer	0.00717	0.0187	CbGbCtD
Cyclophosphamide—CYP2D6—Doxorubicin—stomach cancer	0.00698	0.0182	CbGbCtD
Cyclophosphamide—CYP3A4—Docetaxel—stomach cancer	0.00595	0.0155	CbGbCtD
Cyclophosphamide—CYP3A4—Doxorubicin—stomach cancer	0.00444	0.0116	CbGbCtD
Cyclophosphamide—Ifosfamide—CYP2A6—stomach cancer	0.00218	1	CrCbGaD
Cyclophosphamide—CYP2C18—digestive system—stomach cancer	0.000531	0.0596	CbGeAlD
Cyclophosphamide—CYP2C18—endocrine gland—stomach cancer	0.000439	0.0492	CbGeAlD
Cyclophosphamide—CYP3A7—endocrine gland—stomach cancer	0.000417	0.0468	CbGeAlD
Cyclophosphamide—CYP2C18—liver—stomach cancer	0.000396	0.0444	CbGeAlD
Cyclophosphamide—CYP3A7—liver—stomach cancer	0.000376	0.0422	CbGeAlD
Cyclophosphamide—CYP2C19—hematopoietic system—stomach cancer	0.000325	0.0364	CbGeAlD
Cyclophosphamide—CYP3A7-CYP3A51P—liver—stomach cancer	0.00032	0.0359	CbGeAlD
Cyclophosphamide—CYP2C8—hematopoietic system—stomach cancer	0.000283	0.0318	CbGeAlD
Cyclophosphamide—CYP2A6—liver—stomach cancer	0.000261	0.0293	CbGeAlD
Cyclophosphamide—CYP3A5—hematopoietic system—stomach cancer	0.000256	0.0287	CbGeAlD
Cyclophosphamide—ABCB1—blood vessel—stomach cancer	0.000255	0.0286	CbGeAlD
Cyclophosphamide—CYP2B6—hematopoietic system—stomach cancer	0.000254	0.0285	CbGeAlD
Cyclophosphamide—CYP2C9—hematopoietic system—stomach cancer	0.000252	0.0282	CbGeAlD
Cyclophosphamide—CYP2C19—digestive system—stomach cancer	0.000226	0.0253	CbGeAlD
Cyclophosphamide—CYP3A5—pancreas—stomach cancer	0.000208	0.0234	CbGeAlD
Cyclophosphamide—CYP3A4—hematopoietic system—stomach cancer	0.000192	0.0215	CbGeAlD
Cyclophosphamide—CYP2D6—hematopoietic system—stomach cancer	0.000189	0.0212	CbGeAlD
Cyclophosphamide—CYP2C19—endocrine gland—stomach cancer	0.000186	0.0209	CbGeAlD
Cyclophosphamide—CYP2B6—lymphoid tissue—stomach cancer	0.000179	0.0201	CbGeAlD
Cyclophosphamide—CYP3A5—digestive system—stomach cancer	0.000178	0.0199	CbGeAlD
Cyclophosphamide—CYP2B6—digestive system—stomach cancer	0.000177	0.0198	CbGeAlD
Cyclophosphamide—CYP2C9—digestive system—stomach cancer	0.000175	0.0196	CbGeAlD
Cyclophosphamide—CYP2C19—liver—stomach cancer	0.000168	0.0189	CbGeAlD
Cyclophosphamide—CYP2C8—endocrine gland—stomach cancer	0.000163	0.0183	CbGeAlD
Cyclophosphamide—CYP3A5—endocrine gland—stomach cancer	0.000147	0.0165	CbGeAlD
Cyclophosphamide—CYP2C8—liver—stomach cancer	0.000147	0.0165	CbGeAlD
Cyclophosphamide—CYP2B6—endocrine gland—stomach cancer	0.000146	0.0164	CbGeAlD
Cyclophosphamide—CYP2C9—endocrine gland—stomach cancer	0.000145	0.0162	CbGeAlD
Cyclophosphamide—ABCB1—hematopoietic system—stomach cancer	0.000136	0.0152	CbGeAlD
Cyclophosphamide—CYP3A4—digestive system—stomach cancer	0.000133	0.015	CbGeAlD
Cyclophosphamide—CYP3A5—liver—stomach cancer	0.000132	0.0149	CbGeAlD
Cyclophosphamide—CYP2B6—liver—stomach cancer	0.000132	0.0148	CbGeAlD
Cyclophosphamide—CYP2D6—digestive system—stomach cancer	0.000131	0.0147	CbGeAlD
Cyclophosphamide—CYP2C9—liver—stomach cancer	0.00013	0.0146	CbGeAlD
Cyclophosphamide—ABCB1—epithelium—stomach cancer	0.000124	0.0139	CbGeAlD
Cyclophosphamide—ABCB1—pancreas—stomach cancer	0.000111	0.0124	CbGeAlD
Cyclophosphamide—CYP3A4—endocrine gland—stomach cancer	0.00011	0.0124	CbGeAlD
Cyclophosphamide—CYP2D6—endocrine gland—stomach cancer	0.000108	0.0122	CbGeAlD
Cyclophosphamide—CYP3A4—liver—stomach cancer	9.94e-05	0.0111	CbGeAlD
Cyclophosphamide—CYP2D6—liver—stomach cancer	9.78e-05	0.011	CbGeAlD
Cyclophosphamide—ABCB1—lymphoid tissue—stomach cancer	9.56e-05	0.0107	CbGeAlD
Cyclophosphamide—ABCB1—digestive system—stomach cancer	9.44e-05	0.0106	CbGeAlD
Cyclophosphamide—ABCB1—bone marrow—stomach cancer	8.71e-05	0.00977	CbGeAlD
Cyclophosphamide—ABCB1—endocrine gland—stomach cancer	7.8e-05	0.00875	CbGeAlD
Cyclophosphamide—ABCB1—liver—stomach cancer	7.04e-05	0.00789	CbGeAlD
Cyclophosphamide—Confusional state—Docetaxel—stomach cancer	6.14e-05	0.000256	CcSEcCtD
Cyclophosphamide—Oedema—Docetaxel—stomach cancer	6.09e-05	0.000254	CcSEcCtD
Cyclophosphamide—Anaphylactic shock—Docetaxel—stomach cancer	6.09e-05	0.000254	CcSEcCtD
Cyclophosphamide—Weight increased—Doxorubicin—stomach cancer	6.08e-05	0.000254	CcSEcCtD
Cyclophosphamide—Discomfort—Capecitabine—stomach cancer	6.08e-05	0.000253	CcSEcCtD
Cyclophosphamide—Infection—Docetaxel—stomach cancer	6.05e-05	0.000252	CcSEcCtD
Cyclophosphamide—Hyperglycaemia—Doxorubicin—stomach cancer	6.03e-05	0.000251	CcSEcCtD
Cyclophosphamide—Diarrhoea—Irinotecan—stomach cancer	6.03e-05	0.000251	CcSEcCtD
Cyclophosphamide—Agranulocytosis—Epirubicin—stomach cancer	6.01e-05	0.000251	CcSEcCtD
Cyclophosphamide—Pneumonia—Doxorubicin—stomach cancer	5.99e-05	0.00025	CcSEcCtD
Cyclophosphamide—Shock—Docetaxel—stomach cancer	5.99e-05	0.00025	CcSEcCtD
Cyclophosphamide—Pruritus—Fluorouracil—stomach cancer	5.97e-05	0.000249	CcSEcCtD
Cyclophosphamide—Thrombocytopenia—Docetaxel—stomach cancer	5.96e-05	0.000249	CcSEcCtD
Cyclophosphamide—Visual impairment—Methotrexate—stomach cancer	5.95e-05	0.000248	CcSEcCtD
Cyclophosphamide—Confusional state—Capecitabine—stomach cancer	5.95e-05	0.000248	CcSEcCtD
Cyclophosphamide—Tachycardia—Docetaxel—stomach cancer	5.94e-05	0.000248	CcSEcCtD
Cyclophosphamide—Stevens-Johnson syndrome—Doxorubicin—stomach cancer	5.91e-05	0.000246	CcSEcCtD
Cyclophosphamide—Oedema—Capecitabine—stomach cancer	5.9e-05	0.000246	CcSEcCtD
Cyclophosphamide—Bradycardia—Epirubicin—stomach cancer	5.89e-05	0.000245	CcSEcCtD
Cyclophosphamide—Renal failure—Doxorubicin—stomach cancer	5.86e-05	0.000244	CcSEcCtD
Cyclophosphamide—Infection—Capecitabine—stomach cancer	5.86e-05	0.000244	CcSEcCtD
Cyclophosphamide—Erythema multiforme—Methotrexate—stomach cancer	5.84e-05	0.000244	CcSEcCtD
Cyclophosphamide—Neuropathy peripheral—Doxorubicin—stomach cancer	5.84e-05	0.000244	CcSEcCtD
Cyclophosphamide—Dizziness—Irinotecan—stomach cancer	5.83e-05	0.000243	CcSEcCtD
Cyclophosphamide—Haemoglobin—Epirubicin—stomach cancer	5.81e-05	0.000242	CcSEcCtD
Cyclophosphamide—Stomatitis—Doxorubicin—stomach cancer	5.81e-05	0.000242	CcSEcCtD
Cyclophosphamide—Jaundice—Doxorubicin—stomach cancer	5.81e-05	0.000242	CcSEcCtD
Cyclophosphamide—Anorexia—Docetaxel—stomach cancer	5.81e-05	0.000242	CcSEcCtD
Cyclophosphamide—Shock—Capecitabine—stomach cancer	5.8e-05	0.000242	CcSEcCtD
Cyclophosphamide—Rhinitis—Epirubicin—stomach cancer	5.8e-05	0.000242	CcSEcCtD
Cyclophosphamide—Conjunctivitis—Doxorubicin—stomach cancer	5.79e-05	0.000242	CcSEcCtD
Cyclophosphamide—Haemorrhage—Epirubicin—stomach cancer	5.78e-05	0.000241	CcSEcCtD
Cyclophosphamide—Hepatitis—Epirubicin—stomach cancer	5.78e-05	0.000241	CcSEcCtD
Cyclophosphamide—Diarrhoea—Fluorouracil—stomach cancer	5.77e-05	0.000241	CcSEcCtD
Cyclophosphamide—Thrombocytopenia—Capecitabine—stomach cancer	5.77e-05	0.000241	CcSEcCtD
Cyclophosphamide—Tinnitus—Methotrexate—stomach cancer	5.76e-05	0.00024	CcSEcCtD
Cyclophosphamide—Tachycardia—Capecitabine—stomach cancer	5.75e-05	0.00024	CcSEcCtD
Cyclophosphamide—Hypoaesthesia—Epirubicin—stomach cancer	5.75e-05	0.00024	CcSEcCtD
Cyclophosphamide—Sweating—Doxorubicin—stomach cancer	5.71e-05	0.000238	CcSEcCtD
Cyclophosphamide—Hyperhidrosis—Capecitabine—stomach cancer	5.7e-05	0.000238	CcSEcCtD
Cyclophosphamide—Hypotension—Docetaxel—stomach cancer	5.69e-05	0.000237	CcSEcCtD
Cyclophosphamide—Haematuria—Doxorubicin—stomach cancer	5.68e-05	0.000237	CcSEcCtD
Cyclophosphamide—Anorexia—Capecitabine—stomach cancer	5.62e-05	0.000234	CcSEcCtD
Cyclophosphamide—Vomiting—Irinotecan—stomach cancer	5.6e-05	0.000234	CcSEcCtD
Cyclophosphamide—Dizziness—Fluorouracil—stomach cancer	5.58e-05	0.000233	CcSEcCtD
Cyclophosphamide—Visual impairment—Epirubicin—stomach cancer	5.57e-05	0.000232	CcSEcCtD
Cyclophosphamide—Agranulocytosis—Doxorubicin—stomach cancer	5.56e-05	0.000232	CcSEcCtD
Cyclophosphamide—Rash—Irinotecan—stomach cancer	5.55e-05	0.000232	CcSEcCtD
Cyclophosphamide—Dermatitis—Irinotecan—stomach cancer	5.55e-05	0.000231	CcSEcCtD
Cyclophosphamide—Musculoskeletal discomfort—Docetaxel—stomach cancer	5.55e-05	0.000231	CcSEcCtD
Cyclophosphamide—Chills—Methotrexate—stomach cancer	5.54e-05	0.000231	CcSEcCtD
Cyclophosphamide—Headache—Irinotecan—stomach cancer	5.52e-05	0.00023	CcSEcCtD
Cyclophosphamide—Hypotension—Capecitabine—stomach cancer	5.51e-05	0.00023	CcSEcCtD
Cyclophosphamide—Paraesthesia—Docetaxel—stomach cancer	5.47e-05	0.000228	CcSEcCtD
Cyclophosphamide—Erythema multiforme—Epirubicin—stomach cancer	5.47e-05	0.000228	CcSEcCtD
Cyclophosphamide—Alopecia—Methotrexate—stomach cancer	5.46e-05	0.000228	CcSEcCtD
Cyclophosphamide—Bradycardia—Doxorubicin—stomach cancer	5.45e-05	0.000227	CcSEcCtD
Cyclophosphamide—Dyspnoea—Docetaxel—stomach cancer	5.43e-05	0.000226	CcSEcCtD
Cyclophosphamide—ABCB1—lymph node—stomach cancer	5.39e-05	0.00605	CbGeAlD
Cyclophosphamide—Tinnitus—Epirubicin—stomach cancer	5.39e-05	0.000225	CcSEcCtD
Cyclophosphamide—Erythema—Methotrexate—stomach cancer	5.38e-05	0.000224	CcSEcCtD
Cyclophosphamide—Haemoglobin—Doxorubicin—stomach cancer	5.38e-05	0.000224	CcSEcCtD
Cyclophosphamide—Musculoskeletal discomfort—Capecitabine—stomach cancer	5.37e-05	0.000224	CcSEcCtD
Cyclophosphamide—Flushing—Epirubicin—stomach cancer	5.37e-05	0.000224	CcSEcCtD
Cyclophosphamide—Vomiting—Fluorouracil—stomach cancer	5.37e-05	0.000224	CcSEcCtD
Cyclophosphamide—Rhinitis—Doxorubicin—stomach cancer	5.36e-05	0.000224	CcSEcCtD
Cyclophosphamide—Haemorrhage—Doxorubicin—stomach cancer	5.35e-05	0.000223	CcSEcCtD
Cyclophosphamide—Hepatitis—Doxorubicin—stomach cancer	5.35e-05	0.000223	CcSEcCtD
Cyclophosphamide—Hypoaesthesia—Doxorubicin—stomach cancer	5.32e-05	0.000222	CcSEcCtD
Cyclophosphamide—Rash—Fluorouracil—stomach cancer	5.32e-05	0.000222	CcSEcCtD
Cyclophosphamide—Dermatitis—Fluorouracil—stomach cancer	5.32e-05	0.000222	CcSEcCtD
Cyclophosphamide—Paraesthesia—Capecitabine—stomach cancer	5.29e-05	0.000221	CcSEcCtD
Cyclophosphamide—Decreased appetite—Docetaxel—stomach cancer	5.29e-05	0.000221	CcSEcCtD
Cyclophosphamide—Headache—Fluorouracil—stomach cancer	5.29e-05	0.00022	CcSEcCtD
Cyclophosphamide—Dysgeusia—Methotrexate—stomach cancer	5.27e-05	0.00022	CcSEcCtD
Cyclophosphamide—Dyspnoea—Capecitabine—stomach cancer	5.26e-05	0.000219	CcSEcCtD
Cyclophosphamide—Fatigue—Docetaxel—stomach cancer	5.25e-05	0.000219	CcSEcCtD
Cyclophosphamide—Nausea—Irinotecan—stomach cancer	5.23e-05	0.000218	CcSEcCtD
Cyclophosphamide—Constipation—Docetaxel—stomach cancer	5.21e-05	0.000217	CcSEcCtD
Cyclophosphamide—Pain—Docetaxel—stomach cancer	5.21e-05	0.000217	CcSEcCtD
Cyclophosphamide—Chills—Epirubicin—stomach cancer	5.19e-05	0.000216	CcSEcCtD
Cyclophosphamide—Arrhythmia—Epirubicin—stomach cancer	5.17e-05	0.000215	CcSEcCtD
Cyclophosphamide—Visual impairment—Doxorubicin—stomach cancer	5.16e-05	0.000215	CcSEcCtD
Cyclophosphamide—Decreased appetite—Capecitabine—stomach cancer	5.13e-05	0.000214	CcSEcCtD
Cyclophosphamide—Alopecia—Epirubicin—stomach cancer	5.11e-05	0.000213	CcSEcCtD
Cyclophosphamide—Fatigue—Capecitabine—stomach cancer	5.08e-05	0.000212	CcSEcCtD
Cyclophosphamide—Vision blurred—Methotrexate—stomach cancer	5.07e-05	0.000211	CcSEcCtD
Cyclophosphamide—Erythema multiforme—Doxorubicin—stomach cancer	5.06e-05	0.000211	CcSEcCtD
Cyclophosphamide—Constipation—Capecitabine—stomach cancer	5.04e-05	0.00021	CcSEcCtD
Cyclophosphamide—Pain—Capecitabine—stomach cancer	5.04e-05	0.00021	CcSEcCtD
Cyclophosphamide—Erythema—Epirubicin—stomach cancer	5.03e-05	0.00021	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Docetaxel—stomach cancer	5.02e-05	0.000209	CcSEcCtD
Cyclophosphamide—Nausea—Fluorouracil—stomach cancer	5.01e-05	0.000209	CcSEcCtD
Cyclophosphamide—Ill-defined disorder—Methotrexate—stomach cancer	4.99e-05	0.000208	CcSEcCtD
Cyclophosphamide—Tinnitus—Doxorubicin—stomach cancer	4.99e-05	0.000208	CcSEcCtD
Cyclophosphamide—Anaemia—Methotrexate—stomach cancer	4.97e-05	0.000207	CcSEcCtD
Cyclophosphamide—Flushing—Doxorubicin—stomach cancer	4.97e-05	0.000207	CcSEcCtD
Cyclophosphamide—Dysgeusia—Epirubicin—stomach cancer	4.93e-05	0.000205	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Capecitabine—stomach cancer	4.86e-05	0.000203	CcSEcCtD
Cyclophosphamide—Malaise—Methotrexate—stomach cancer	4.85e-05	0.000202	CcSEcCtD
Cyclophosphamide—Muscle spasms—Epirubicin—stomach cancer	4.84e-05	0.000202	CcSEcCtD
Cyclophosphamide—Body temperature increased—Docetaxel—stomach cancer	4.81e-05	0.000201	CcSEcCtD
Cyclophosphamide—Leukopenia—Methotrexate—stomach cancer	4.81e-05	0.000201	CcSEcCtD
Cyclophosphamide—Chills—Doxorubicin—stomach cancer	4.8e-05	0.0002	CcSEcCtD
Cyclophosphamide—Arrhythmia—Doxorubicin—stomach cancer	4.78e-05	0.000199	CcSEcCtD
Cyclophosphamide—Vision blurred—Epirubicin—stomach cancer	4.74e-05	0.000198	CcSEcCtD
Cyclophosphamide—Alopecia—Doxorubicin—stomach cancer	4.73e-05	0.000197	CcSEcCtD
Cyclophosphamide—Cough—Methotrexate—stomach cancer	4.69e-05	0.000196	CcSEcCtD
Cyclophosphamide—Urticaria—Capecitabine—stomach cancer	4.68e-05	0.000195	CcSEcCtD
Cyclophosphamide—Ill-defined disorder—Epirubicin—stomach cancer	4.67e-05	0.000195	CcSEcCtD
Cyclophosphamide—Body temperature increased—Capecitabine—stomach cancer	4.66e-05	0.000194	CcSEcCtD
Cyclophosphamide—Convulsion—Methotrexate—stomach cancer	4.66e-05	0.000194	CcSEcCtD
Cyclophosphamide—Erythema—Doxorubicin—stomach cancer	4.66e-05	0.000194	CcSEcCtD
Cyclophosphamide—Anaemia—Epirubicin—stomach cancer	4.65e-05	0.000194	CcSEcCtD
Cyclophosphamide—Agitation—Epirubicin—stomach cancer	4.63e-05	0.000193	CcSEcCtD
Cyclophosphamide—Myalgia—Methotrexate—stomach cancer	4.58e-05	0.000191	CcSEcCtD
Cyclophosphamide—Chest pain—Methotrexate—stomach cancer	4.58e-05	0.000191	CcSEcCtD
Cyclophosphamide—Arthralgia—Methotrexate—stomach cancer	4.58e-05	0.000191	CcSEcCtD
Cyclophosphamide—Dysgeusia—Doxorubicin—stomach cancer	4.56e-05	0.00019	CcSEcCtD
Cyclophosphamide—Malaise—Epirubicin—stomach cancer	4.54e-05	0.000189	CcSEcCtD
Cyclophosphamide—Discomfort—Methotrexate—stomach cancer	4.52e-05	0.000189	CcSEcCtD
Cyclophosphamide—Leukopenia—Epirubicin—stomach cancer	4.51e-05	0.000188	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Docetaxel—stomach cancer	4.49e-05	0.000187	CcSEcCtD
Cyclophosphamide—Muscle spasms—Doxorubicin—stomach cancer	4.48e-05	0.000187	CcSEcCtD
Cyclophosphamide—Palpitations—Epirubicin—stomach cancer	4.45e-05	0.000185	CcSEcCtD
Cyclophosphamide—Confusional state—Methotrexate—stomach cancer	4.43e-05	0.000185	CcSEcCtD
Cyclophosphamide—Cough—Epirubicin—stomach cancer	4.39e-05	0.000183	CcSEcCtD
Cyclophosphamide—Anaphylactic shock—Methotrexate—stomach cancer	4.39e-05	0.000183	CcSEcCtD
Cyclophosphamide—Vision blurred—Doxorubicin—stomach cancer	4.39e-05	0.000183	CcSEcCtD
Cyclophosphamide—Asthenia—Docetaxel—stomach cancer	4.37e-05	0.000182	CcSEcCtD
Cyclophosphamide—Convulsion—Epirubicin—stomach cancer	4.36e-05	0.000182	CcSEcCtD
Cyclophosphamide—Infection—Methotrexate—stomach cancer	4.36e-05	0.000182	CcSEcCtD
Cyclophosphamide—Hypertension—Epirubicin—stomach cancer	4.35e-05	0.000181	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Capecitabine—stomach cancer	4.34e-05	0.000181	CcSEcCtD
Cyclophosphamide—Ill-defined disorder—Doxorubicin—stomach cancer	4.32e-05	0.00018	CcSEcCtD
Cyclophosphamide—Pruritus—Docetaxel—stomach cancer	4.31e-05	0.00018	CcSEcCtD
Cyclophosphamide—Anaemia—Doxorubicin—stomach cancer	4.3e-05	0.000179	CcSEcCtD
Cyclophosphamide—Thrombocytopenia—Methotrexate—stomach cancer	4.3e-05	0.000179	CcSEcCtD
Cyclophosphamide—Myalgia—Epirubicin—stomach cancer	4.29e-05	0.000179	CcSEcCtD
Cyclophosphamide—Chest pain—Epirubicin—stomach cancer	4.29e-05	0.000179	CcSEcCtD
Cyclophosphamide—Arthralgia—Epirubicin—stomach cancer	4.29e-05	0.000179	CcSEcCtD
Cyclophosphamide—Agitation—Doxorubicin—stomach cancer	4.28e-05	0.000178	CcSEcCtD
Cyclophosphamide—Hyperhidrosis—Methotrexate—stomach cancer	4.24e-05	0.000177	CcSEcCtD
Cyclophosphamide—Discomfort—Epirubicin—stomach cancer	4.23e-05	0.000177	CcSEcCtD
Cyclophosphamide—Asthenia—Capecitabine—stomach cancer	4.23e-05	0.000176	CcSEcCtD
Cyclophosphamide—Malaise—Doxorubicin—stomach cancer	4.2e-05	0.000175	CcSEcCtD
Cyclophosphamide—Anorexia—Methotrexate—stomach cancer	4.18e-05	0.000174	CcSEcCtD
Cyclophosphamide—Pruritus—Capecitabine—stomach cancer	4.17e-05	0.000174	CcSEcCtD
Cyclophosphamide—Leukopenia—Doxorubicin—stomach cancer	4.17e-05	0.000174	CcSEcCtD
Cyclophosphamide—Diarrhoea—Docetaxel—stomach cancer	4.17e-05	0.000174	CcSEcCtD
Cyclophosphamide—Confusional state—Epirubicin—stomach cancer	4.14e-05	0.000173	CcSEcCtD
Cyclophosphamide—Palpitations—Doxorubicin—stomach cancer	4.12e-05	0.000172	CcSEcCtD
Cyclophosphamide—Oedema—Epirubicin—stomach cancer	4.11e-05	0.000171	CcSEcCtD
Cyclophosphamide—Anaphylactic shock—Epirubicin—stomach cancer	4.11e-05	0.000171	CcSEcCtD
Cyclophosphamide—Hypotension—Methotrexate—stomach cancer	4.1e-05	0.000171	CcSEcCtD
Cyclophosphamide—Infection—Epirubicin—stomach cancer	4.08e-05	0.00017	CcSEcCtD
Cyclophosphamide—Cough—Doxorubicin—stomach cancer	4.06e-05	0.000169	CcSEcCtD
Cyclophosphamide—Shock—Epirubicin—stomach cancer	4.04e-05	0.000168	CcSEcCtD
Cyclophosphamide—Convulsion—Doxorubicin—stomach cancer	4.04e-05	0.000168	CcSEcCtD
Cyclophosphamide—Diarrhoea—Capecitabine—stomach cancer	4.03e-05	0.000168	CcSEcCtD
Cyclophosphamide—Dizziness—Docetaxel—stomach cancer	4.03e-05	0.000168	CcSEcCtD
Cyclophosphamide—Thrombocytopenia—Epirubicin—stomach cancer	4.02e-05	0.000168	CcSEcCtD
Cyclophosphamide—Hypertension—Doxorubicin—stomach cancer	4.02e-05	0.000168	CcSEcCtD
Cyclophosphamide—Tachycardia—Epirubicin—stomach cancer	4.01e-05	0.000167	CcSEcCtD
Cyclophosphamide—Musculoskeletal discomfort—Methotrexate—stomach cancer	4e-05	0.000167	CcSEcCtD
Cyclophosphamide—Hyperhidrosis—Epirubicin—stomach cancer	3.97e-05	0.000166	CcSEcCtD
Cyclophosphamide—Arthralgia—Doxorubicin—stomach cancer	3.96e-05	0.000165	CcSEcCtD
Cyclophosphamide—Myalgia—Doxorubicin—stomach cancer	3.96e-05	0.000165	CcSEcCtD
Cyclophosphamide—Chest pain—Doxorubicin—stomach cancer	3.96e-05	0.000165	CcSEcCtD
Cyclophosphamide—Paraesthesia—Methotrexate—stomach cancer	3.94e-05	0.000164	CcSEcCtD
Cyclophosphamide—Discomfort—Doxorubicin—stomach cancer	3.92e-05	0.000163	CcSEcCtD
Cyclophosphamide—Anorexia—Epirubicin—stomach cancer	3.92e-05	0.000163	CcSEcCtD
Cyclophosphamide—Dyspnoea—Methotrexate—stomach cancer	3.91e-05	0.000163	CcSEcCtD
Cyclophosphamide—Dizziness—Capecitabine—stomach cancer	3.9e-05	0.000163	CcSEcCtD
Cyclophosphamide—Vomiting—Docetaxel—stomach cancer	3.87e-05	0.000161	CcSEcCtD
Cyclophosphamide—Rash—Docetaxel—stomach cancer	3.84e-05	0.00016	CcSEcCtD
Cyclophosphamide—Hypotension—Epirubicin—stomach cancer	3.84e-05	0.00016	CcSEcCtD
Cyclophosphamide—Dermatitis—Docetaxel—stomach cancer	3.84e-05	0.00016	CcSEcCtD
Cyclophosphamide—Confusional state—Doxorubicin—stomach cancer	3.83e-05	0.00016	CcSEcCtD
Cyclophosphamide—Decreased appetite—Methotrexate—stomach cancer	3.82e-05	0.000159	CcSEcCtD
Cyclophosphamide—Headache—Docetaxel—stomach cancer	3.82e-05	0.000159	CcSEcCtD
Cyclophosphamide—Anaphylactic shock—Doxorubicin—stomach cancer	3.8e-05	0.000158	CcSEcCtD
Cyclophosphamide—Oedema—Doxorubicin—stomach cancer	3.8e-05	0.000158	CcSEcCtD
Cyclophosphamide—Fatigue—Methotrexate—stomach cancer	3.78e-05	0.000158	CcSEcCtD
Cyclophosphamide—Infection—Doxorubicin—stomach cancer	3.78e-05	0.000157	CcSEcCtD
Cyclophosphamide—Pain—Methotrexate—stomach cancer	3.75e-05	0.000156	CcSEcCtD
Cyclophosphamide—Vomiting—Capecitabine—stomach cancer	3.75e-05	0.000156	CcSEcCtD
Cyclophosphamide—Musculoskeletal discomfort—Epirubicin—stomach cancer	3.74e-05	0.000156	CcSEcCtD
Cyclophosphamide—Shock—Doxorubicin—stomach cancer	3.74e-05	0.000156	CcSEcCtD
Cyclophosphamide—Thrombocytopenia—Doxorubicin—stomach cancer	3.72e-05	0.000155	CcSEcCtD
Cyclophosphamide—Rash—Capecitabine—stomach cancer	3.72e-05	0.000155	CcSEcCtD
Cyclophosphamide—Dermatitis—Capecitabine—stomach cancer	3.71e-05	0.000155	CcSEcCtD
Cyclophosphamide—Tachycardia—Doxorubicin—stomach cancer	3.71e-05	0.000155	CcSEcCtD
Cyclophosphamide—Headache—Capecitabine—stomach cancer	3.69e-05	0.000154	CcSEcCtD
Cyclophosphamide—Paraesthesia—Epirubicin—stomach cancer	3.69e-05	0.000154	CcSEcCtD
Cyclophosphamide—Hyperhidrosis—Doxorubicin—stomach cancer	3.67e-05	0.000153	CcSEcCtD
Cyclophosphamide—Dyspnoea—Epirubicin—stomach cancer	3.66e-05	0.000153	CcSEcCtD
Cyclophosphamide—Anorexia—Doxorubicin—stomach cancer	3.62e-05	0.000151	CcSEcCtD
Cyclophosphamide—Nausea—Docetaxel—stomach cancer	3.62e-05	0.000151	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Methotrexate—stomach cancer	3.62e-05	0.000151	CcSEcCtD
Cyclophosphamide—Decreased appetite—Epirubicin—stomach cancer	3.57e-05	0.000149	CcSEcCtD
Cyclophosphamide—Hypotension—Doxorubicin—stomach cancer	3.55e-05	0.000148	CcSEcCtD
Cyclophosphamide—Fatigue—Epirubicin—stomach cancer	3.54e-05	0.000148	CcSEcCtD
Cyclophosphamide—Pain—Epirubicin—stomach cancer	3.51e-05	0.000146	CcSEcCtD
Cyclophosphamide—Constipation—Epirubicin—stomach cancer	3.51e-05	0.000146	CcSEcCtD
Cyclophosphamide—Nausea—Capecitabine—stomach cancer	3.5e-05	0.000146	CcSEcCtD
Cyclophosphamide—Urticaria—Methotrexate—stomach cancer	3.49e-05	0.000145	CcSEcCtD
Cyclophosphamide—Body temperature increased—Methotrexate—stomach cancer	3.47e-05	0.000145	CcSEcCtD
Cyclophosphamide—Musculoskeletal discomfort—Doxorubicin—stomach cancer	3.46e-05	0.000144	CcSEcCtD
Cyclophosphamide—Paraesthesia—Doxorubicin—stomach cancer	3.41e-05	0.000142	CcSEcCtD
Cyclophosphamide—Dyspnoea—Doxorubicin—stomach cancer	3.39e-05	0.000141	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Epirubicin—stomach cancer	3.39e-05	0.000141	CcSEcCtD
Cyclophosphamide—Decreased appetite—Doxorubicin—stomach cancer	3.3e-05	0.000138	CcSEcCtD
Cyclophosphamide—Fatigue—Doxorubicin—stomach cancer	3.28e-05	0.000137	CcSEcCtD
Cyclophosphamide—Urticaria—Epirubicin—stomach cancer	3.26e-05	0.000136	CcSEcCtD
Cyclophosphamide—Pain—Doxorubicin—stomach cancer	3.25e-05	0.000136	CcSEcCtD
Cyclophosphamide—Constipation—Doxorubicin—stomach cancer	3.25e-05	0.000136	CcSEcCtD
Cyclophosphamide—Body temperature increased—Epirubicin—stomach cancer	3.25e-05	0.000135	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Methotrexate—stomach cancer	3.23e-05	0.000135	CcSEcCtD
Cyclophosphamide—Asthenia—Methotrexate—stomach cancer	3.15e-05	0.000131	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Doxorubicin—stomach cancer	3.13e-05	0.000131	CcSEcCtD
Cyclophosphamide—Pruritus—Methotrexate—stomach cancer	3.11e-05	0.000129	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Epirubicin—stomach cancer	3.03e-05	0.000126	CcSEcCtD
Cyclophosphamide—Urticaria—Doxorubicin—stomach cancer	3.02e-05	0.000126	CcSEcCtD
Cyclophosphamide—Body temperature increased—Doxorubicin—stomach cancer	3e-05	0.000125	CcSEcCtD
Cyclophosphamide—Diarrhoea—Methotrexate—stomach cancer	3e-05	0.000125	CcSEcCtD
Cyclophosphamide—Asthenia—Epirubicin—stomach cancer	2.95e-05	0.000123	CcSEcCtD
Cyclophosphamide—Pruritus—Epirubicin—stomach cancer	2.91e-05	0.000121	CcSEcCtD
Cyclophosphamide—Dizziness—Methotrexate—stomach cancer	2.9e-05	0.000121	CcSEcCtD
Cyclophosphamide—Diarrhoea—Epirubicin—stomach cancer	2.81e-05	0.000117	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Doxorubicin—stomach cancer	2.8e-05	0.000117	CcSEcCtD
Cyclophosphamide—Vomiting—Methotrexate—stomach cancer	2.79e-05	0.000116	CcSEcCtD
Cyclophosphamide—Rash—Methotrexate—stomach cancer	2.77e-05	0.000115	CcSEcCtD
Cyclophosphamide—Dermatitis—Methotrexate—stomach cancer	2.77e-05	0.000115	CcSEcCtD
Cyclophosphamide—Headache—Methotrexate—stomach cancer	2.75e-05	0.000115	CcSEcCtD
Cyclophosphamide—Asthenia—Doxorubicin—stomach cancer	2.73e-05	0.000114	CcSEcCtD
Cyclophosphamide—Dizziness—Epirubicin—stomach cancer	2.72e-05	0.000113	CcSEcCtD
Cyclophosphamide—Pruritus—Doxorubicin—stomach cancer	2.69e-05	0.000112	CcSEcCtD
Cyclophosphamide—Vomiting—Epirubicin—stomach cancer	2.61e-05	0.000109	CcSEcCtD
Cyclophosphamide—Nausea—Methotrexate—stomach cancer	2.61e-05	0.000109	CcSEcCtD
Cyclophosphamide—Diarrhoea—Doxorubicin—stomach cancer	2.6e-05	0.000108	CcSEcCtD
Cyclophosphamide—Rash—Epirubicin—stomach cancer	2.59e-05	0.000108	CcSEcCtD
Cyclophosphamide—Dermatitis—Epirubicin—stomach cancer	2.59e-05	0.000108	CcSEcCtD
Cyclophosphamide—Headache—Epirubicin—stomach cancer	2.57e-05	0.000107	CcSEcCtD
Cyclophosphamide—Dizziness—Doxorubicin—stomach cancer	2.51e-05	0.000105	CcSEcCtD
Cyclophosphamide—Nausea—Epirubicin—stomach cancer	2.44e-05	0.000102	CcSEcCtD
Cyclophosphamide—Vomiting—Doxorubicin—stomach cancer	2.42e-05	0.000101	CcSEcCtD
Cyclophosphamide—Rash—Doxorubicin—stomach cancer	2.4e-05	9.99e-05	CcSEcCtD
Cyclophosphamide—Dermatitis—Doxorubicin—stomach cancer	2.39e-05	9.98e-05	CcSEcCtD
Cyclophosphamide—Headache—Doxorubicin—stomach cancer	2.38e-05	9.93e-05	CcSEcCtD
Cyclophosphamide—Nausea—Doxorubicin—stomach cancer	2.26e-05	9.41e-05	CcSEcCtD
Cyclophosphamide—CYP2B6—Metabolism—CYP2A6—stomach cancer	6.92e-06	0.000263	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	6.91e-06	0.000263	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—SREBF2—stomach cancer	6.89e-06	0.000263	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	6.89e-06	0.000263	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—TYMP—stomach cancer	6.88e-06	0.000262	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—FADS1—stomach cancer	6.88e-06	0.000262	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—GSTT1—stomach cancer	6.84e-06	0.000261	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—RORA—stomach cancer	6.81e-06	0.000259	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—ALOX5—stomach cancer	6.81e-06	0.000259	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—CYP2A6—stomach cancer	6.76e-06	0.000258	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—AKR1C3—stomach cancer	6.73e-06	0.000256	CbGpPWpGaD
Cyclophosphamide—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—stomach cancer	6.73e-06	0.000256	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—DPYD—stomach cancer	6.7e-06	0.000255	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—PPP2R1A—stomach cancer	6.69e-06	0.000255	CbGpPWpGaD
Cyclophosphamide—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—stomach cancer	6.67e-06	0.000254	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—AKR1C3—stomach cancer	6.58e-06	0.000251	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—GSTP1—stomach cancer	6.56e-06	0.00025	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—ENO1—stomach cancer	6.56e-06	0.00025	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—ALDOB—stomach cancer	6.54e-06	0.000249	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—PPARG—stomach cancer	6.5e-06	0.000247	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—SREBF2—stomach cancer	6.49e-06	0.000247	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—HMOX1—stomach cancer	6.47e-06	0.000246	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—SREBF2—stomach cancer	6.44e-06	0.000245	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—RORA—stomach cancer	6.42e-06	0.000244	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—ENO1—stomach cancer	6.41e-06	0.000244	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—ALDOB—stomach cancer	6.38e-06	0.000243	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—CA1—stomach cancer	6.36e-06	0.000242	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—CKB—stomach cancer	6.36e-06	0.000242	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—FBP1—stomach cancer	6.36e-06	0.000242	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—NDUFA2—stomach cancer	6.36e-06	0.000242	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—RORA—stomach cancer	6.36e-06	0.000242	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	6.16e-06	0.000235	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	6.15e-06	0.000234	CbGpPWpGaD
Cyclophosphamide—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—stomach cancer	6.13e-06	0.000234	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—PPP2R1A—stomach cancer	6.13e-06	0.000233	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—TYMS—stomach cancer	6.1e-06	0.000232	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—ALOX5—stomach cancer	6.08e-06	0.000232	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	6.07e-06	0.000231	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—GSTM1—stomach cancer	6.03e-06	0.00023	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—ALDOB—stomach cancer	6.01e-06	0.000229	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—GSTP1—stomach cancer	6.01e-06	0.000229	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—PLIN2—stomach cancer	5.98e-06	0.000228	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—DPYD—stomach cancer	5.98e-06	0.000228	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—ALDOB—stomach cancer	5.96e-06	0.000227	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—ALOX5—stomach cancer	5.93e-06	0.000226	CbGpPWpGaD
Cyclophosphamide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—stomach cancer	5.93e-06	0.000226	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—HMOX1—stomach cancer	5.93e-06	0.000226	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—GSTT1—stomach cancer	5.92e-06	0.000226	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—CYP2A6—stomach cancer	5.86e-06	0.000223	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—ALB—stomach cancer	5.84e-06	0.000223	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—DPYD—stomach cancer	5.84e-06	0.000222	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—CA2—stomach cancer	5.82e-06	0.000222	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—CD44—stomach cancer	5.82e-06	0.000222	CbGpPWpGaD
Cyclophosphamide—ABCB1—Transmembrane transport of small molecules—APOA1—stomach cancer	5.71e-06	0.000217	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—AKR1C3—stomach cancer	5.7e-06	0.000217	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—CD44—stomach cancer	5.68e-06	0.000217	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—PGAM1—stomach cancer	5.67e-06	0.000216	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—NT5E—stomach cancer	5.67e-06	0.000216	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—ERCC2—stomach cancer	5.67e-06	0.000216	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	5.62e-06	0.000214	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	5.61e-06	0.000214	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—ALOX5—stomach cancer	5.59e-06	0.000213	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—TYMS—stomach cancer	5.59e-06	0.000213	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—NOS3—stomach cancer	5.59e-06	0.000213	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—ENO1—stomach cancer	5.55e-06	0.000211	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—ALOX5—stomach cancer	5.54e-06	0.000211	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—GSTM1—stomach cancer	5.52e-06	0.00021	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—DPYD—stomach cancer	5.5e-06	0.00021	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism of lipids and lipoproteins—ALB—stomach cancer	5.46e-06	0.000208	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—DPYD—stomach cancer	5.45e-06	0.000208	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	5.42e-06	0.000206	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—ALDH7A1—stomach cancer	5.41e-06	0.000206	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—PLCE1—stomach cancer	5.41e-06	0.000206	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—MTHFR—stomach cancer	5.33e-06	0.000203	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—GSTT1—stomach cancer	5.29e-06	0.000201	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—CYP2A6—stomach cancer	5.23e-06	0.000199	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—ERCC2—stomach cancer	5.19e-06	0.000198	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—UMPS—stomach cancer	5.19e-06	0.000198	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—GSTT1—stomach cancer	5.16e-06	0.000197	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—PTGS2—stomach cancer	5.11e-06	0.000195	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—CYP2A6—stomach cancer	5.1e-06	0.000194	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—AKR1C3—stomach cancer	5.08e-06	0.000194	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—AKR1C3—stomach cancer	4.96e-06	0.000189	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—ENO1—stomach cancer	4.95e-06	0.000189	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—PPP2R1A—stomach cancer	4.94e-06	0.000188	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	4.94e-06	0.000188	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—CD44—stomach cancer	4.92e-06	0.000188	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—CAV1—stomach cancer	4.91e-06	0.000187	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—APOA1—stomach cancer	4.9e-06	0.000187	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—MTHFR—stomach cancer	4.88e-06	0.000186	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—stomach cancer	4.87e-06	0.000186	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—GSTT1—stomach cancer	4.86e-06	0.000185	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—GSTP1—stomach cancer	4.85e-06	0.000185	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—ENO1—stomach cancer	4.84e-06	0.000184	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—PPP2R1A—stomach cancer	4.83e-06	0.000184	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—PDHA1—stomach cancer	4.82e-06	0.000184	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—ECHS1—stomach cancer	4.82e-06	0.000184	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—GSTT1—stomach cancer	4.82e-06	0.000184	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—CYP2A6—stomach cancer	4.81e-06	0.000183	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—HMOX1—stomach cancer	4.78e-06	0.000182	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	4.78e-06	0.000182	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—CYP2A6—stomach cancer	4.77e-06	0.000182	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—GSTP1—stomach cancer	4.74e-06	0.000181	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—AKR1C3—stomach cancer	4.68e-06	0.000178	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—HMOX1—stomach cancer	4.68e-06	0.000178	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—AKR1C3—stomach cancer	4.64e-06	0.000177	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—ENO1—stomach cancer	4.56e-06	0.000174	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—TYMP—stomach cancer	4.53e-06	0.000173	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—FADS1—stomach cancer	4.53e-06	0.000173	CbGpPWpGaD
Cyclophosphamide—ABCB1—Transmembrane transport of small molecules—ALB—stomach cancer	4.52e-06	0.000172	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—ENO1—stomach cancer	4.52e-06	0.000172	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—TYMS—stomach cancer	4.51e-06	0.000172	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—CAV1—stomach cancer	4.5e-06	0.000172	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—APOA1—stomach cancer	4.49e-06	0.000171	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—GSTM1—stomach cancer	4.46e-06	0.00017	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—stomach cancer	4.44e-06	0.000169	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—TYMS—stomach cancer	4.41e-06	0.000168	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—CD44—stomach cancer	4.39e-06	0.000167	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—GSTM1—stomach cancer	4.36e-06	0.000166	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—PPARG—stomach cancer	4.32e-06	0.000165	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—CD44—stomach cancer	4.29e-06	0.000163	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	4.26e-06	0.000162	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—SREBF2—stomach cancer	4.25e-06	0.000162	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—RORA—stomach cancer	4.2e-06	0.00016	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—ERCC2—stomach cancer	4.19e-06	0.00016	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—PPP2R1A—stomach cancer	4.19e-06	0.000159	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—GSTP1—stomach cancer	4.11e-06	0.000156	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—ERCC2—stomach cancer	4.1e-06	0.000156	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—HMOX1—stomach cancer	4.05e-06	0.000154	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—CD44—stomach cancer	4.04e-06	0.000154	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—CD44—stomach cancer	4.01e-06	0.000153	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—PPARG—stomach cancer	3.96e-06	0.000151	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—MTHFR—stomach cancer	3.94e-06	0.00015	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—ALDOB—stomach cancer	3.93e-06	0.00015	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	3.89e-06	0.000148	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—ALB—stomach cancer	3.88e-06	0.000148	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—MTHFR—stomach cancer	3.85e-06	0.000147	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—TYMS—stomach cancer	3.82e-06	0.000145	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—GSTM1—stomach cancer	3.77e-06	0.000144	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—PPP2R1A—stomach cancer	3.74e-06	0.000142	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—NOS3—stomach cancer	3.71e-06	0.000142	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—GSTP1—stomach cancer	3.67e-06	0.00014	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—ALOX5—stomach cancer	3.65e-06	0.000139	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—PPP2R1A—stomach cancer	3.65e-06	0.000139	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—CAV1—stomach cancer	3.63e-06	0.000138	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—APOA1—stomach cancer	3.63e-06	0.000138	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—HMOX1—stomach cancer	3.61e-06	0.000138	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—DPYD—stomach cancer	3.6e-06	0.000137	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—GSTP1—stomach cancer	3.58e-06	0.000136	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—ALB—stomach cancer	3.56e-06	0.000136	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—CAV1—stomach cancer	3.55e-06	0.000135	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—ERCC2—stomach cancer	3.55e-06	0.000135	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—APOA1—stomach cancer	3.54e-06	0.000135	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—HMOX1—stomach cancer	3.53e-06	0.000134	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—PPP2R1A—stomach cancer	3.44e-06	0.000131	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—TYMS—stomach cancer	3.41e-06	0.00013	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—PPP2R1A—stomach cancer	3.41e-06	0.00013	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—NOS3—stomach cancer	3.4e-06	0.00013	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—PTGS2—stomach cancer	3.4e-06	0.000129	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—GSTP1—stomach cancer	3.37e-06	0.000128	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—GSTM1—stomach cancer	3.37e-06	0.000128	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—GSTP1—stomach cancer	3.34e-06	0.000127	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—MTHFR—stomach cancer	3.33e-06	0.000127	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—TYMS—stomach cancer	3.33e-06	0.000127	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—HMOX1—stomach cancer	3.32e-06	0.000127	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—HMOX1—stomach cancer	3.3e-06	0.000126	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—GSTM1—stomach cancer	3.29e-06	0.000125	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—PPARG—stomach cancer	3.19e-06	0.000122	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—GSTT1—stomach cancer	3.18e-06	0.000121	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—ERCC2—stomach cancer	3.17e-06	0.000121	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—PIK3CA—stomach cancer	3.14e-06	0.00012	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—CYP2A6—stomach cancer	3.14e-06	0.00012	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—TYMS—stomach cancer	3.13e-06	0.000119	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—PPARG—stomach cancer	3.12e-06	0.000119	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—PTGS2—stomach cancer	3.11e-06	0.000119	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—TYMS—stomach cancer	3.11e-06	0.000118	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—GSTM1—stomach cancer	3.1e-06	0.000118	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—ERCC2—stomach cancer	3.09e-06	0.000118	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—CAV1—stomach cancer	3.08e-06	0.000117	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—GSTM1—stomach cancer	3.07e-06	0.000117	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—APOA1—stomach cancer	3.07e-06	0.000117	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—AKR1C3—stomach cancer	3.06e-06	0.000116	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—ENO1—stomach cancer	2.98e-06	0.000114	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—MTHFR—stomach cancer	2.98e-06	0.000113	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	2.94e-06	0.000112	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—ERCC2—stomach cancer	2.91e-06	0.000111	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—MTHFR—stomach cancer	2.91e-06	0.000111	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—ERCC2—stomach cancer	2.89e-06	0.00011	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—ALB—stomach cancer	2.87e-06	0.000109	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—ALB—stomach cancer	2.81e-06	0.000107	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—NOS3—stomach cancer	2.75e-06	0.000105	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—CAV1—stomach cancer	2.75e-06	0.000105	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—APOA1—stomach cancer	2.74e-06	0.000104	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—MTHFR—stomach cancer	2.74e-06	0.000104	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—MTHFR—stomach cancer	2.71e-06	0.000103	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—PPARG—stomach cancer	2.7e-06	0.000103	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—NOS3—stomach cancer	2.69e-06	0.000102	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—CAV1—stomach cancer	2.68e-06	0.000102	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—APOA1—stomach cancer	2.67e-06	0.000102	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—CD44—stomach cancer	2.64e-06	0.000101	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	2.62e-06	9.99e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—CAV1—stomach cancer	2.53e-06	9.62e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—APOA1—stomach cancer	2.52e-06	9.6e-05	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—PTGS2—stomach cancer	2.51e-06	9.57e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—CAV1—stomach cancer	2.5e-06	9.54e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—APOA1—stomach cancer	2.5e-06	9.51e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—PTGS2—stomach cancer	2.46e-06	9.36e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—ALB—stomach cancer	2.43e-06	9.26e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—PPARG—stomach cancer	2.41e-06	9.19e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	2.39e-06	9.11e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—PPARG—stomach cancer	2.36e-06	8.97e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—NOS3—stomach cancer	2.33e-06	8.86e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—PPP2R1A—stomach cancer	2.25e-06	8.56e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—PPARG—stomach cancer	2.22e-06	8.46e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—GSTP1—stomach cancer	2.2e-06	8.4e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—PPARG—stomach cancer	2.2e-06	8.38e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—HMOX1—stomach cancer	2.17e-06	8.28e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—ALB—stomach cancer	2.17e-06	8.27e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—PTGS2—stomach cancer	2.13e-06	8.1e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—ALB—stomach cancer	2.12e-06	8.07e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—PIK3CA—stomach cancer	2.09e-06	7.96e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—NOS3—stomach cancer	2.08e-06	7.91e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—TYMS—stomach cancer	2.05e-06	7.81e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—NOS3—stomach cancer	2.03e-06	7.72e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—GSTM1—stomach cancer	2.03e-06	7.72e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—ALB—stomach cancer	2e-06	7.6e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—ALB—stomach cancer	1.98e-06	7.54e-05	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—PIK3CA—stomach cancer	1.92e-06	7.3e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—NOS3—stomach cancer	1.91e-06	7.27e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—ERCC2—stomach cancer	1.9e-06	7.25e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—PTGS2—stomach cancer	1.9e-06	7.23e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—NOS3—stomach cancer	1.89e-06	7.21e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—PTGS2—stomach cancer	1.85e-06	7.06e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—MTHFR—stomach cancer	1.79e-06	6.82e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—PTGS2—stomach cancer	1.75e-06	6.65e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—PTGS2—stomach cancer	1.73e-06	6.6e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—CAV1—stomach cancer	1.65e-06	6.29e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—APOA1—stomach cancer	1.65e-06	6.28e-05	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—PIK3CA—stomach cancer	1.55e-06	5.89e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—PIK3CA—stomach cancer	1.51e-06	5.76e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—PPARG—stomach cancer	1.45e-06	5.53e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—PIK3CA—stomach cancer	1.31e-06	4.99e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—ALB—stomach cancer	1.31e-06	4.97e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—NOS3—stomach cancer	1.25e-06	4.76e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—PIK3CA—stomach cancer	1.17e-06	4.45e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—PTGS2—stomach cancer	1.14e-06	4.35e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—PIK3CA—stomach cancer	1.14e-06	4.34e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—PIK3CA—stomach cancer	1.07e-06	4.09e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—PIK3CA—stomach cancer	1.07e-06	4.06e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—PIK3CA—stomach cancer	7.02e-07	2.68e-05	CbGpPWpGaD
